Haemostasis Flashcards

1
Q

What are the 3 stages of the cell-based theory of coagulation?

A
  1. Initiation
  2. Amplification
  3. Propagation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Summarise the events of the initiation stage of coagulation

A

Small-scale production of thrombin on TF-bearing cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the mechanism by which TF triggers thrombin production

A

TF-bearing cells activate Factors X and V
FX and FV trigger formation of the prothrombinase complex
Prothrombinase complex activates factor II –> IIa (prothrombin –> thrombin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism of action of antithrombin?

A

Inactivates thrombin (FIIa) and Factir Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What class of drugs targets the initiation phase of coagulation?

A

Anti-coagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Recall an example of a factor IIa inhibitor

A

Dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Recall an example of a factor Xa inhibitor

A

Rivaroxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Recall the mechanism of action of heparin

A

Activates antithrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Recall an example of a low-molecular weight heparin

A

Dalteparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mechanism of action of warfarin

A

Inhibits Vit K which is essential for generation of factors II, VII, IX and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the main indication for anti-coagulant use?

A

VENOUS thrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Recall 3 examples of when anti-coagulant therapy may be used

A

DVT
Thrombosis during surgery
Stroke prevention in AF patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Summarise the events of the amplification stage of coagulation

A

Large-scale production of thrombin on platelets, overwhelming anti-thrombin to lead to platelet activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Recall the 2 ways in which PAR activation brings about platelet aggregation

A
  1. PAR activation –> rise in IC CA++. Ca++ –> ADP exocytosis from dense granules. ADP auto-activates platelets via ADP receptor called P2Y12 –> platelet aggregation
  2. PAR activation –> arachdionic acid production –> TXA2 generation –> GPIIb and GPIIIa expression –> platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the biochemical mechanism by which thrombin triggers platelet-aggregation pathways

A

Binds to Protease-Activated-Receptor (PAR) on platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give 3 examples of anti-platelet drugs

A
  1. Clopidogrel
  2. Aspirin
  3. Abciximab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Recall the mechanism of action of clopidogrel

A

ADP-receptor antagonist - prevents platelet activation + aggregation

18
Q

Recall the mechanism of action of aspirin

A

Irreversible COX1 inhibitor - inhibits TXA1 production

19
Q

Recall the mechanism of action of abciximab

A

Inhibits GPIIb/IIIa receptor –> inhibition of platelet aggregation

20
Q

What is the main indication for anti-platelet drugs?

A

ARTERIAL thromboses

21
Q

Differentiate the treatment strategies for NSTEMIs and STEMIs

A

NSTEMI: anti-platelet to reduce lipid accumulation + platelet aggregation
STEMI: need anti-platelet to reduce lipids and platelet aggregation as well as a thrombolytic to dissolve thrombus as it is bigger

22
Q

Summarise the events of the propagation phase of coagulation

A

Thrombin-mediated generation of fibrin strands from circulatory fibrinogen

23
Q

What is the normal physiological function of fibrin

A

Fibrin strands come together to form a net that holds clot together

24
Q

What sort of drugs are used to target the propagation phase of coagulation

A

Thrombolytics - these can reduce a pre-formed clot

25
Q

Within what time-frame are thrombolytics effective?

A

30 mins

26
Q

Recall the general mechanism of action of thrombolytics

A

Activate plasmin from plasminogen, plasmin-protease degraded fibrin

27
Q

Recall an example of a thrombolytuc drug

A

Alteplase = recombinant plasminogen activator

28
Q

Recall 2 possible occasions when thrombolytics might be used

A

First-line treatment for stroke

ST-elevated MI (STEMI)

29
Q

Recall 4 examples of pro-coagulant clotting factors in plasma

A

Prothrombin
Factor V
Factor VII
Fibrinogen

30
Q

Recall 4 examples of anti-coagulant clotting factors in plasma

A

Plasminogen
TFPI
Proteins C and S
Antithrombin

31
Q

Differentiate the composition and site of red and white thrombi

A
Red = high fibrin component, forms within veins
White = high platelet component, forms within atherosclerotic plaque
32
Q

What is the main risk associated with red thrombi?

A

Life-threatening emboli

33
Q

What is the main risk associated with white thrombi?

A

Plaque rupture to release thrombus into arterial lumen and cause ischaemia

34
Q

Recall the triad of factors that lead to thrombus production

A
  1. Low rate of blood flow
  2. Consistency of blood
  3. Vessel wall integrity
35
Q

How does blood flow rate affect risk of thrombus production?

A

Anticoagulant factors are not replenished due to stagnant flow

36
Q

What does the term “consistency” refer to in the blood?

A

Balance of pro- and anti-coagulant factors (NOT viscosity)

37
Q

Give an example of a disorder that result in high consistency of blood

A

Factor V Leiden - it cannot be inactivated by the normal factor V-deactivating processes

38
Q

What drugs are used to combat thrombus production?

A

Anti-coagulants

39
Q

What are the 2 main CVD disease states associated with venous pathology?

A

DVT

PE

40
Q

What are the 2 main CVD disease states associated with arterial pathology?

A

Stroke
Acute coronary syndrome
Aortic aneurysm
AF